Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 10/31/07
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 09/30/07
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 10/31/07
End: -
Due: -
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Two Different Schedules of Carboplatin, Paclitaxel, Gemcitabine, and Surgery in Treating Patients With Newly Diagnosed Stage IIIC or Stage IV Primary Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer | NCT00838656 | Warwick Medical School | user2@example.com | None | 2007-10-31 | - | - | - | - | 2025-07-14 |
| PET/CT Scan-Guided Watchful Waiting or Neck Dissection of Locally Advanced Lymph Node Metastases in Treating Patients Undergoing Chemotherapy and Radiation Therapy for Primary Head And Neck Cancer | NCT00720070 | Warwick Medical School | user2@example.com | None | 2007-09-30 | - | - | - | - | 2025-07-14 |
| Trastuzumab in Treating Women With HER2-Positive Early Breast Cancer | NCT00712140 | Warwick Medical School | user2@example.com | None | 2007-10-31 | - | - | - | - | 2025-07-14 |